Benefits of fluvoxamine confirmed in new study
Preventing hospitalization following COVID-19 infection in vulnerable populations
Life-Threatening Illness National Group (LifTING) Research Training Platform funded
Congratulations to Dr. Patricia Fontela!
Michael S. Kramer awarded the Prix du chercheur émérite 2020-2021 by the RRSPQ
The RI-MUHC senior scientist will present a seminar on “Maternal and child population health...
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Cardiovascular care following a heart attack influenced by unemployment—and more so in the US than Canada, study suggests
New RI-MUHC study shows that health systems and unemployment influence...
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...